This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, Y. D. Articles by Tomita, J. T. Search for Related Content PubMed PubMed Citation Articles by Kim, Y. D. Articles by Tomita, J. T.

Molecular Characterization of the Epitope in Prostate and Breast Tumor-associated PR92 Antigen

Diagnostics Division, D90C, Abbott Laboratories, North Chicago, Illinois 60064

In our previous report, monoclonal antibody PR92 has defined prostate- and breast tumor-associated PR92 antigen. The molecular nature of PR92 antigen, especially the epitope involved in specific interaction with PR92 monoclonal antibody, is described. PR92 antigen was purified from the cell extract or tissue culture medium of prostate cancer cell line DU145 by means of monoclonal antibody-coupled Sepharose 4B affinity chromatography, followed by a Sephacryl S-500 chromatography. Physical and chemical characterization, coupled with high-performance liquid chromatography, determined that PR92 antigen is a glycoprotein with a molecular weight of about 470,000, comprising repeating subunits of about 44,000. Sialic acid was found to form a critical part, while D-galactose and N-acetylgalactosamine were also involved, in the epitope structure. PR92 antigen is rich in serine, threonine, proline, glycine, and alanine and poor in aromatic amino acid residues. The carbohydrate moieties may be predominantly O-linked to polypeptide chains which contribute directly or indirectly to maintain the integrity of the epitope. Elucidation of the molecular nature of PR92 antigen may help understand the mechanism of shedding into the body fluids during tumor progression.

¹ To whom requests for reprints should be addressed.

Received 7/13/88. Revised 10/21/88. Accepted 1/25/89.

This article has been cited by other articles:

				J. Xu, J. A. Stolk, X. Zhang, S. J. Silva, R. L. Houghton, M. Matsumura, T. S. Vedvick, K. B. Leslie, R. Badaro, and S. G. Reed Identification of Differentially Expressed Genes in Human Prostate Cancer Using Subtraction and Microarray Cancer Res., March 1, 2000; 60(6): 1677 - 1682. [Abstract] [Full Text]